Vera Therapeutics (NASDAQ:VERA) Coverage Initiated at Cantor Fitzgerald

Cantor Fitzgerald assumed coverage on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research report report published on Monday morning, Marketbeat.com reports. The firm issued an overweight rating on the stock. VERA has been the subject of a number of other research reports. HC Wainwright reissued a buy rating and set a $25.00 […]

Leave a Reply

Your email address will not be published.

Previous post TMX Group (TSE:X) PT Raised to C$34.00 at Barclays
Next post B. Riley Downgrades WhiteHorse Finance (NASDAQ:WHF) to Neutral